LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry
Author:
Funder
Tianjin Medical University
National Natural Science Foundation of China
Natural Science Foundation of Tianjin City
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference53 articles.
1. Hepatocellular carcinoma epidemiology;Bosetti;Best Pract Res Clin Gastroenterol,2014
2. Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients;Zhang;Cancer Biol Med,2016
3. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma;Erstad;Ann Surg Oncol,2019
4. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma;Fu;J Exp Clin Cancer Res: CR,2019
5. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma;Wong;Hepatology (Baltimore, Md.),2014
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor-Intrinsic Perinuclear LOXL2: Prognostic Relevance and Relationship with YAP1 Activation Status in Oral Squamous Cell Carcinoma;Pathobiology;2024-06-27
2. The role of LOXL2 in tumor progression, immune response and cellular senescence: a comprehensive analysis;Discover Oncology;2024-06-26
3. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis;Expert Opinion on Pharmacotherapy;2024-05-02
4. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets;Frontiers in Pharmacology;2024-04-17
5. LOXL2 in Cancer: A Two-Decade Perspective;International Journal of Molecular Sciences;2023-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3